|1.||Scala, Antonio: 1 article (03/2003)|
|2.||Toma, Lucio: 1 article (03/2003)|
|3.||Tokuda, Harukuni: 1 article (03/2003)|
|4.||Ronchetti, Fiamma: 1 article (03/2003)|
|5.||Colombo, Diego: 1 article (03/2003)|
|6.||Nishino, Hoyoku: 1 article (03/2003)|
|1.||Endometrial Neoplasms (Endometrial Cancer)
08/01/1995 - "The results suggested that AG was effective in treating patients with endometrial cancer, resulting in changes of endocrine environments and inhibition of cell growth by mechanism different from that of hydroxyprogesterone caproates."
08/01/1995 - "[Comparison between the roles of aminoglutethimide and hydroxyprogesterone caproates in the treatment of endometrial cancer]."
03/20/2003 - "The inhibitory effect of the resultant isomeric hexanoates at the primary alcoholic positions, beta-D-galactosylethylene glycol itself and nonyl beta-D-galactopyranoside, was tested on Epstein-Barr virus early antigen (EBV-EA) activation in Raji cells promoted by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA), as a primary screening test for inhibitors of tumor promotion. "
|3.||Epstein-Barr virus early antigen